2024-06-25 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 8,301 0.0063% | $230.99 | $1.92M | +6.14% | |
2024-02-28 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 2,932 0.0023% | $155.31 | $455,357 | -3.37% | |
2024-02-16 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 7,030 0.0056% | $148.06 | $1.04M | +2.09% | |
2024-02-16 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 6,190 0.005% | $147.93 | $915,699 | +2.09% | |
2023-08-04 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 4,057 0.0033% | $185.85 | $753,986 | -11.05% | |
2023-04-27 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 7,615 0.0061% | $194.59 | $1.48M | -8.05% | |
2021-08-06 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President & COO | 53,064 0.0454% | $199.00 | $10.56M | -16.84% | |
2021-01-12 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President & COO | 3,125 0.0026% | $161.00 | $503,125 | +3.25% | |
2020-07-10 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Operating Officer | 46,639 0.0399% | $161.00 | $7.51M | -13.76% | |
2020-07-09 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Operating Officer | 11,236 0.0098% | $161.00 | $1.81M | -11.82% | |
2020-05-06 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Operating Officer | 50,000 0.0449% | $150.00 | $7.5M | -4.35% | |
2020-05-05 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Operating Officer | 7,811 0.0067% | $140.00 | $1.09M | -1.47% | |
2020-02-10 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Operating Officer | 9,892 0.0087% | $130.00 | $1.29M | +3.18% | |
2020-02-07 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Operating Officer | 6,250 0.0055% | $123.90 | $774,375 | +7.8% | |
2019-11-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Operating Officer | 8,404 0.0073% | $105.00 | $882,420 | +20.75% | |
2018-08-30 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Operating Officer | 5,000 0.0049% | $120.00 | $600,000 | -34.01% | |
2018-03-26 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Operating Officer | 14,442 0.0142% | $136.54 | $1.97M | -34.06% |